DNAAF11

Chr 8AR

dynein axonemal assembly factor 11

Also known as: CILD19, LRRC6, LRTP, TSLRP, tilB

The protein encoded by this gene contains several leucine-rich repeat domains and appears to be involved in the motility of cilia. Defects in this gene are a cause of primary ciliary dyskinesia-19 (CILD19). Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 4, 11 and 22. [provided by RefSeq, Apr 2016]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 1.081 OMIM phenotype
Clinical SummaryDNAAF11
🧬
Gene-Disease Validity (ClinGen)
primary ciliary dyskinesia 19 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
51 unique Pathogenic / Likely Pathogenic· 137 VUS of 362 total submissions
💊
Clinical Trials
9 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — DNAAF11
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.08LOEUF
pLI 0.000
Z-score 1.23
OE 0.74 (0.511.08)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.13Z-score
OE missense 1.02 (0.921.14)
243 obs / 237.4 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.74 (0.511.08)
00.351.4
Missense OE?1.02 (0.921.14)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 19 / 25.7Missense obs/exp: 243 / 237.4Syn Z: -0.14
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveDNAAF11-related primary ciliary dyskinesiaLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.7130th %ile
GOF
0.6540th %ile
LOF
0.2386th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

362 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic17
VUS137
Likely Benign119
Benign24
Conflicting18
34
Pathogenic
17
Likely Pathogenic
137
VUS
119
Likely Benign
24
Benign
18
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
31
2
1
0
34
Likely Pathogenic
12
3
2
0
17
VUS
2
119
16
0
137
Likely Benign
0
6
52
61
119
Benign
0
3
19
2
24
Conflicting
18
Total451339063349

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

55 pathogenic / likely-pathogenic (of 65) ClinVar copy-number / structural variants overlap DNAAF11 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

DNAAF11 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

Rectal Cancer PatientsObesity &Amp; OverweightLocally Advanced Rectal Cancer (LARC)

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

NOT YET RECRUITING
NCT07314528Phase PHASE2St. James's Hospital, IrelandStarted 2026-04
GLP-1 receptor agonistTotal neoadjuvant therapy (TNT)
Female Infertility

Female Fertility, Environmental Agents and Stress Oxidant

RECRUITING
NCT04866329University Hospital, ToursStarted 2021-12-08
Blood sampleUrine sampleFollicular fluid and granulosa cells sample
VaccinationImmunosenescenceMetabolism

VITAL: Vaccination, Immunity, Time-restricted Eating, Aging and Lifestyle

RECRUITING
NCT07000708Phase NACharite University, Berlin, GermanyStarted 2025-09-10
TRE: Time-restricted eating
Melanoma

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

RECRUITING
NCT04658303Yana NajjarStarted 2021-02-24
Pimonidazole
Porphyria, Acute Intermittent

Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

RECRUITING
NCT06273644Phase NANordlandssykehuset HFStarted 2024-01-27
Carbohydrates
CystinosisNative Kidney

Cystinosis and Mitochondrial Metabolism

NOT YET RECRUITING
NCT07319091Phase NAHospices Civils de LyonStarted 2026-01
Mitochondrial metabolism
Transgender Individuals

Effects of Gender-Affirming Hormone Therapy on Cardiovascular, Metabolic, and Mental Health Outcomes in Transgender Adults.

NOT YET RECRUITING
NCT07394400Milagros Rocha BarajasStarted 2026-02-14
Endometriosis

" Development of Primary Cultures of Diaphragmatic Myoblasts for Basic Research Purposes "

NOT YET RECRUITING
NCT07380308Assistance Publique - Hôpitaux de ParisStarted 2026-02-01
During the surgery planned as part of the routine care of the patient, a part of the tissue sample will be saved in order to carry out the analysis planned for the research.
Healthy

Tocotrienol Supplementa as A Senolytic Agent in Middle-aged Adults

RECRUITING
NCT07637487Phase NANational University of MalaysiaStarted 2023-10-31
TreatmentPlacebo